Teva Pharmaceutical Industries (TEVA) Minority Interest (2016 - 2025)
Historic Minority Interest for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q3 2025 value amounting to $4.0 million.
- Teva Pharmaceutical Industries' Minority Interest fell 9874.61% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 9874.61%. This contributed to the annual value of $340.0 million for FY2024, which is 4516.13% down from last year.
- Teva Pharmaceutical Industries' Minority Interest amounted to $4.0 million in Q3 2025, which was down 9874.61% from $7.0 million recorded in Q2 2025.
- Teva Pharmaceutical Industries' 5-year Minority Interest high stood at $987.0 million for Q2 2021, and its period low was $4.0 million during Q3 2025.
- In the last 5 years, Teva Pharmaceutical Industries' Minority Interest had a median value of $656.0 million in 2023 and averaged $574.7 million.
- In the last 5 years, Teva Pharmaceutical Industries' Minority Interest soared by 154.32% in 2021 and then crashed by 9874.61% in 2025.
- Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Minority Interest stood at $966.0 million in 2021, then fell by 17.81% to $794.0 million in 2022, then dropped by 21.91% to $620.0 million in 2023, then plummeted by 45.16% to $340.0 million in 2024, then plummeted by 98.82% to $4.0 million in 2025.
- Its Minority Interest stands at $4.0 million for Q3 2025, versus $7.0 million for Q2 2025 and $7.0 million for Q1 2025.